A new strategy, superenzyme gene therapy in penile rehabilitation

Journal of Sexual Medicine

Volumn 6, Issue SUPPL. 3, 2009, Pages 328-333

  Yuan, Jiuhong ^a   Westney, O Lenaine ^a   Ruan, Ke He ^b   Wang, Run ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Penile rehabilitation; Radical prostatectomy; SuperEnzyme

Indexed keywords

ADENOVIRUS VECTOR; ARACHIDONIC ACID; COMPLEMENTARY DNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN; RECOMBINANT ENZYME; SUPERENZYME; UNCLASSIFIED DRUG;

APOPTOSIS; CONFERENCE PAPER; DRUG MECHANISM; ERECTILE DYSFUNCTION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HYPOXIA; MOLECULAR BIOLOGY; NERVE INJURY; NONHUMAN; PATHOPHYSIOLOGY; PENILE BLOOD FLOW; PENILE FIBROSIS; PENIS ERECTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTATECTOMY; PROTEIN ENGINEERING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; VIRAL GENE THERAPY;

EID: 61849086853     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01191.x     Document Type: Conference Paper

References (47)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
2. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58-61.
3. Wang R. Penile rehabilitation after radical prostatectomy: Where do we stand and where are we going? J Sex Med 2007; 4: 1085-97.
4. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35.
5. Levine LA. Erectile dysfunction following treatment of prostate cancer: New insights and therapeutic options. J Men's Health Gen 2004; 1: 328-33.
6. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The prostate cancer outcomes study. JAMA 2000; 283: 354-60.
7. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004; 45: 123-33.
8. Karakiewicz PI, Bhojani N, Neugut A, Shariat SF, Jeldres C, Graefen M, Perrotte P, Peloquin F, Kattan MW. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. J Sex Med 2008; 5: 919-27.
9. Chartier-Kastler E, Amar E, Chevallier D, Montaigne O, Coulange C, Joubert JM, Giuliano F. Does management of erectile dysfunction after radical prostatectomy meet patients' expectations? Results of a national survey (REPAIR) by the French Urological Association. J Sex Med 2008; 5: 693-704.
10. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E. How urologists manage erectile dysfunction after radical prostatectomy: A national survey (REPAIR) by the French urological association. J Sex Med 2008; 5: 448-57.
11. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007; 4: 538-43.
12. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I, American Urological Association Prostate Cancer Guideline Update Panel. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 2007; 178: 597-601.
13. Burnett AL, Allaf ME, Bivalacqua TJ. Erythropoietin promotes erection recovery after nerve-sparing radical retropubic prostatectomy: A retrospective analysis. J Sex Med 2008; 5: 2392-8.
14. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin CS, Pohl J, Lue TF. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2008; 5: 1866-75.
15. Ruan KH, Deng H, So SP. Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin. Biochemistry 2006; 45: 14003-11.
16. Burnett AL. Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy: Results from CaPSURE. J Urol 2004; 171: 703-8.
17. Fraiman MC, Eepor H, McCullough AR. Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol Urol 1999; 3: 109-15.
18. Mulhall JP, Graydon RJ. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996; 8: 91-4.
19. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, Flanigan RC. Erectile dysfunction after radical prostatectomy: Hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371-5.
20. Lim KB, DeYoung L, Brock G. Chronic PDES inhibitor altered cavernosal protein expression-use in identifying protein biomarker for erectile recovery post trauma? J Sex Med 2006; 3 (5 suppl): 383-4 (Abstract OR-006).
21. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175-9.
22. McVary KT, Podlasek CA, Wood D, McKenna KE. Apoptotic pathways are employed in neuropathic and diabetic models of erectile dysfunction. J Urol 2006; 175 (suppl): 387 (Abstract 1203).
23. Moreland RB. Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the society for the study of impotence. Int J Impot Res 1998; 10: 113-20.
24. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003; 24: 239-45.
25. Granchi S, Vannelli GB, Vignozzi L, Crescioli C, Ferruzzi P, Mancina R, Vinci MC, Forti G, Filippi S, Luconi M, Ledda F, Maggi M. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod 2002; 8: 1053-64.
26. Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE 1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995; 153: 826-34.
27. Moreland RB, Gupta S, Goldstein I, Traish A. Cyclic AMP modulates TGF-beta-1 induced fibrillar collagen synthesis in cultured human corpus cavernosum smooth muscle cells. Int J Impot Res 1998; 10: 159-63.
28. Saenz de Tejada I, Morouluan P, Tessier J, Kim JJ, Goldstein I, Frohrib D. Trabecular smooth muscle modulates the capacitor function of the penis. Studies on a rabbit model. Am J Physiol 1991; 260: H1590-5.
29. Gontero P, Kirby R. Proerectile pharmacological prophylaxis following nerve-sparing radical prostatectomy. Prostate Cancer Prostatic Dis 2004; 7: 223-6.
30. Needleman P, Turk J, Jackschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986; 55: 69-102.
31. Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12: 897-913.
32. Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res 1977; 11: 323-44.
33. Weksler BB, Ley CW, Jaffe EA. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest 1978; 62: 923-30.
34. Ingerman-Wojenski C, Silver MJ, Smith JB, Macarak E. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest 1981; 67: 1292-6.
35. Smith WL, DeWitt DL, Allen ML. Biomedical distribution of the prostaglandin I2 synthesis antigen in smooth muscle cells. J Biol Chem 1983; 258: 5922-6.
36. Jakobsson PJ, Thoren S, Morgenstem R, Samuelsson B. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999; 96: 7220-5.
37. Green GA. Understanding NSAIDS: From aspirin to COX-2. Clin Cornerstone 2001; 3: 50-9.
38. Angulo J, Cuevas P, La Fuente JM, Pomerol JM, Ruiz-CastañéE, Puigvert A, Gabancho S, Fernández A, Ney P, Sáenz De Tejada, I. Regulation of human penile smooth muscle tone by prostanoid receptors. Br J Pharmacol 2002; 136: 23-30.
39. Shiri R, Koskimäki J, Häkkinen J, Tammela TL, Auvinen A, Hakama M. Effect of nonsteroidal anti-inflammatory drug use on the incidence of erectile dysfunction. J Urol 2006; 175: 1812-5.
40. Christ GJ, Lue T. Physiology and biochemistry of erections. Endocrine 2004; 23: 93-100.
41. Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP. Functional sequelae of cavernous nerve injury in the rat: Is there model dependency. J Sex Med 2006; 3: 77-83.
42. Canguven O, Burnett A. Cavernous nerve injury using rodent animal models. J Sex Med 2008; 5: 1776-85.
43. Goldstein I. Early penile rehabilitation following radical prostatectomy: Overview and rationale. Contemp Urol 2006; 18 (1 suppl): 3-6.
44. Mulhall JP, Müller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, Tal R, Li PS, Cohen-Gould L, Scardino PT. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med 2008; 5: 1126-36.
45. Padma-Nathan H, McCullough AR, Giuliano F, Tolet S, Wohlhuter C, Shpilsky A. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 4 (suppl): 375. abstract 1402, presented at the AUA 2003.
46. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171: 771-4.
47. Wang R, Huber N, Madsen L, Wood C, Babaian R. Compliance to penile rehabilitation program following radical prostatectomy: 1 year data. J Sex Med 2006; 3 (2 suppl): 151 (Abstract-Not numbered).